Product Information
FT MUCUS RELIEF D ER 1,200-120 is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.4235 per EA under NDC 70677127301. Its NADAC has been published 53 times since Apr 2, 2025.
FDA first approved this application on Feb 1, 2022.
Strength
1200; 120 mg/1; mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677127301
Classification
Generic
Dosage Form
TABLET, MULTILAYER, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214407FDA Approved
2/1/2022
On Market Since
11/20/2024
Pharmacological Classes
Price Statistics
The NADAC for FT MUCUS RELIEF D ER 1,200-120 has been published 53 times since Apr 2, 2025, and over the history we have for it it has declined 28.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4235 per EA |
|---|---|
| All-time high | $0.5958 (Aug 13, 2025) |
| All-time low | $0.4177 (Feb 18, 2026) |
| 52-week high | $0.4235 |
| 52-week low | $0.4177 |
| Median price | $0.4231 |
| Average price | $0.4866 |
| Largest weekly change | -29.9% (Feb 18, 2026) |
| Weeks tracked | 53 |
| Tracking since | Apr 2, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
guaifenesin, pseudoephedrine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT MUCUS RELIEF D ER 1,200-120?
The current National Average Drug Acquisition Cost (NADAC) for FT MUCUS RELIEF D ER 1,200-120, manufactured by Strategic Sourcing Services LLC, is $0.4235 per EA (NDC 70677127301), effective Sep 30, 2026.
How has the price of FT MUCUS RELIEF D ER 1,200-120 changed over time?
Over the history we have for it, the NADAC for FT MUCUS RELIEF D ER 1,200-120 has declined 28.9%. It has been tracked across 53 weekly CMS publications since Apr 2, 2025.
What are the highest and lowest recorded NADAC prices for FT MUCUS RELIEF D ER 1,200-120?
Since Apr 2, 2025, the NADAC for FT MUCUS RELIEF D ER 1,200-120 has ranged from a low of $0.4177 (Feb 18, 2026) to a high of $0.5958 (Aug 13, 2025), with a median of $0.4231 per EA.
Are there cheaper alternatives to FT MUCUS RELIEF D ER 1,200-120?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FT MUCUS RELIEF D ER 1,200-120 in a comparable dosage form, but none are currently priced below it.
Who manufactures FT MUCUS RELIEF D ER 1,200-120?
FT MUCUS RELIEF D ER 1,200-120 (NDC 70677127301) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.